Gene Doping Control Analysis of Human Erythropoietin Transgene in Equine Plasma by PCR-Liquid Chromatography High-Resolution Tandem Mass Spectrometry.

The research article looks at the development and application of a new sensitive method, the PCR-Liquid Chromatography High-Resolution Tandem Mass Spectrometry (PCR-LC-HRMS/MS), in detecting gene doping in equine sports, specifically the human Erythropoietin (hEPO) transgene.

Understanding Gene Doping

• Gene doping is a term designating the misuse of genetic material, such as DNA and RNA. It involves manipulating genes to enhance an athlete’s performance, an action prohibited in sports, including equine activities.
• The article primarily focuses on the misuse of the hEPO transgene in equine sports. Erythropoietin (EPO) is a hormone that stimulates the production of red blood cells, increasing the oxygen-carrying capacity of the blood and subsequently enhancing athletic performance.

Existing Methods of Gene Doping Detection

• Prior to this study, Quantitative Polymerase Chain Reaction (qPCR) assays served as the primary tool for detecting gene doping misuse in equine sports.
• This study’s authors mention the development and application of duplex and multiplex qPCR assays in their laboratory for transgenes detection.

Introduction of PCR-LC-HRMS/MS

• To improve gene doping detection, the researchers developed a new method, PCR-Liquid Chromatography High-Resolution Tandem Mass Spectrometry (PCR-LC-HRMS/MS).
• This method is considered sensitive and explicit, with an estimated detection limit of under 100 copies/mL for the hEPO in equine plasma, surpassing previous methods’ detection capabilities.

Documenting the PCR-LC-HRMS/MS Process

• The method begins with the extraction of DNA from equine plasma using magnetic-glass-particle-based extraction. This DNA is then amplified through PCR with 2′-deoxyuridine 5′-triphosphate (dUTP).
• Following this, the treatment of uracil DNA glycosylase and hot piperidine allows for selective cleavage, producing small oligonucleotide fragments.
• The resulting DNA fragments are then identified and analyzed through LC-HRMS/MS.

Proving the Applicability of PCR-LC-HRMS/MS

• The researchers demonstrated the new method’s usability by successfully detecting the hEPO transgene in a blood sample from a gelding (a castrated male horse) whom was administered with the transgene.
• Therefore, not only does PCR-LC-HRMS/MS serve as an advanced method for detecting the presence of a specific transgene (hEPO in this case), it also points to the potential for a more inclusive PCR-LC-HRMS/MS method capable of detecting multiple transgenes in the future.